Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Position Increased by Bouvel Investment Partners LLC

Bouvel Investment Partners LLC lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.9% in the 4th quarter, HoldingsChannel reports. The firm owned 14,356 shares of the medical equipment provider’s stock after purchasing an additional 406 shares during the quarter. Intuitive Surgical makes up about 2.7% of Bouvel Investment Partners LLC’s portfolio, making the stock its 10th largest position. Bouvel Investment Partners LLC’s holdings in Intuitive Surgical were worth $7,493,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of ISRG. Godsey & Gibb Inc. lifted its stake in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical during the 3rd quarter worth about $33,000. Capital Performance Advisors LLP purchased a new position in shares of Intuitive Surgical during the 3rd quarter valued at about $38,000. DT Investment Partners LLC lifted its holdings in shares of Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after buying an additional 36 shares during the period. Finally, Mark Sheptoff Financial Planning LLC acquired a new stake in Intuitive Surgical during the second quarter worth about $37,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 2,553 shares of Intuitive Surgical stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the transaction, the executive vice president now directly owns 7,066 shares in the company, valued at approximately $3,638,990. This trade represents a 26.54 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 48,190 shares of company stock valued at $25,012,927. 0.80% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $584.08 on Friday. The company has a market capitalization of $208.04 billion, a PE ratio of 93.90, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $355.17 and a fifty-two week high of $585.50. The firm has a 50 day moving average price of $538.34 and a 200 day moving average price of $497.08.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Analysts Set New Price Targets

ISRG has been the subject of a number of analyst reports. Robert W. Baird boosted their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Truist Financial boosted their target price on shares of Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, December 18th. Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Wells Fargo & Company raised their target price on Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, December 11th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.